MarketPeel
Insider Trading Intelligence
HA

Harry W. JR Alcorn

DMAC
SVP, CLINICAL OPERATIONS · DIAMEDICA THERAPEUTICS INC. · CIK 0001186761
FILING MIX · LIFETIME100%/0%
BUYS
6
SELLS
0
TOTAL VALUE
$121.0K
COMPANIES
1
ACTIVE SINCE
Jun 2020
HOLDINGS NOW
43,582
AVG SELL PX
TRADE KIND
SHOWING 6 / 6
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
4 backtested trades · 8 horizons
Forward-return performance of every backtestable P/S trade by Harry W. JR Alcorn, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d4+75.00%+12.08%-0.43%+12.51%+16.04%
14d4+100.00%+17.97%+0.21%+17.76%+21.32%
30d4+100.00%+14.71%+0.12%+14.59%+17.42%
60d4+100.00%+19.50%+1.23%+18.27%+24.55%
90d4+75.00%+16.16%+4.63%+11.53%+17.58%
180d4+0.00%-17.83%-2.16%-15.67%-9.54%
1y4+0.00%-48.69%-4.78%-43.91%-41.58%
2y4+0.00%-8.86%+1.65%-10.50%-7.78%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
DMAC · 43,582 shares · as of Sep 15, 2021
015,00030,00045,00060,0002021SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2021
2021
2021
FLOW · 6 buys / 0 sellsCOVERAGE · 6 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILED
DMAC
DIAMEDICA THERAPEUTICS INC.
PURCHASE
SVP, Clinical Operations
15,000$3.80$57.0K43,582Sep 15, 2021Sep 15, 2021
DMAC
DIAMEDICA THERAPEUTICS INC.
PURCHASE
Senior VP, Clinical Operations
399$3.07$1.2K399Aug 16, 2021Aug 16, 2021
DMAC
DIAMEDICA THERAPEUTICS INC.
PURCHASE
Senior VP, Clinical Operations
20,000$3.09$61.8K28,260Aug 16, 2021Aug 16, 2021
DMAC
DIAMEDICA THERAPEUTICS INC.
PURCHASE
Senior VP, Clinical Operations
322$3.06$98528,582Aug 16, 2021Aug 16, 2021
DMAC
DIAMEDICA THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
60,00060,000Jul 28, 2021Jul 29, 2021
DMAC
DIAMEDICA THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
35,00035,000Jun 1, 2020Jun 2, 2020
Other insiders · DMAC
Loading peer insiders…
About this filer
CIK 0001186761
ROLE
SVP, Clinical Operations
PRIMARY
DMAC
COMPANIES
1
ACTIVE SINCE
Jun 2020
MARKETPEEL · /INSIDER/0001186761DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

FeedbackHarry W. JR Alcorn — Insider Trading Activity | MarketPeel